{"nctId":"NCT00221104","briefTitle":"Japan Statin Treatment Against Recurrent Stroke (J-STARS)","startDateStruct":{"date":"2004-03-01"},"conditions":["Ischemic Stroke"],"count":1578,"armGroups":[{"label":"Pravastatin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Pravastatin"]},{"label":"No intervention","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Pravastatin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ischemic stroke except for cardiogenic embolism, from 1 month to 3 years after onset\n* Hyperlipidemia and total cholesterol level of 180-240mg/dl without the prescription of statin within previous 30 days\n* Able to visit outpatient department\n* Informed consent on the form.\n\nExclusion Criteria:\n\n* Ischemic stroke of other determined cause according to the TOAST classification\n* Ischemic heart disease and necessary to use statin\n* Hemorrhagic disorders\n* Platelet count \\<=100,000/ul within 3 months prior to study start\n* Alanine aminotransferase (ALT) or aspartate aminotransferase (AST)\\>= 100IU/L within 3 months prior to study start\n* Serum creatinine \\>=2.0mg/dl within 3 months prior to study start\n* A scheduled operation\n* The presence of malignant disorder","healthyVolunteers":false,"sex":"ALL","minimumAge":"45 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Incidence Rate of Stroke and TIA","description":"Incidence rate of patients with recurrent stroke of any type or transient ischemic attack (TIA)","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.56","spread":null},{"groupId":"OG001","value":"2.65","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence Rate of Atherothrombotic Infarction","description":"Incidence rate of patients with atherothrombotic infarction","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.65","spread":null},{"groupId":"OG001","value":"0.21","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence Rate of Lacunar Infarction","description":"Incidence rate of patients with lacunar infarction","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.26","spread":null},{"groupId":"OG001","value":"1.01","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence Rate of Cardioembolic Infarction","description":"Incidence rate of patients with cardioembolic infarction","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.18","spread":null},{"groupId":"OG001","value":"0.08","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence Rate of Intracranial Hemorrhage","description":"Incidence rate of patients with intracranial hemorrhage","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.29","spread":null},{"groupId":"OG001","value":"0.31","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":188,"n":780},"commonTop":[]}}}